Version 9 of the American Joint Committee on Cancer (AJCC) Cancer Staging System for Neuroendocrine Tumors of the Colon and Rectum brings important updates and enhancements to this critical resource. The revised Version 9 is presented in an accessible and simplified format, designed to facilitate ease of use for physicians, registrars, researchers, and other stakeholders.
Key features of Version 9 include:
Integration of WHO Classification: This updated version now incorporates the World Health Organization (WHO) Classification of Tumors histology codes, ensuring alignment with contemporary classification standards.
Expanded Content: Version 9 offers comprehensive updates, including valuable tables, explanatory notes, and illustrations, which contribute to a deeper understanding and more effective application of the staging system.
Effective Date: Version 9 of the Neuroendocrine Tumors of the Colon and Rectum Cancer Staging System is scheduled to take effect on January 1, 2024. After this date, it will supersede the 8th Edition Neuroendocrine Tumors of the Colon and Rectum content.
These improvements ensure that the AJCC Cancer Staging System for Neuroendocrine Tumors of the Colon and Rectum remains current and continues to serve as a valuable reference for healthcare professionals and researchers in this field.
